Chris Simmons
Vice President, Project Management
Chris Simmons serves as Vice President, Project Management within Worldwide Clinical Trials’ oncology services group. With more than 25 years of experience across project management, operational excellence, quality, and business transformation, Chris helps oncology sponsors successfully navigate complex clinical development programs through strong governance, strategic oversight, and disciplined execution.
Ask Chris a question
Submit an RFP. Ask a Question
Chris began his career as an intern statistician at British Biotech in Oxford. After earning a BSc in Mathematics from the University of Bath, he joined Covance as a statistical programmer and went on to hold roles spanning biometrics, quality, operational excellence, project management, and business transformation.
As a certified Lean Six Sigma Black Belt, Chris led global process improvement initiatives and mentored leaders in continuous improvement methodologies. He went on to establish a global quality management function, implementing enterprise-wide metrics and reporting to assess and improve operational performance. Chris later led the global Project Management Office (PMO), providing governance across a broad clinical project portfolio while overseeing operational processes, CAPA management, and SOP governance.
Prior to joining Worldwide, Chris served as Global Head of Business Transformation at Labcorp Drug Development (formerly Covance), where he led large-scale strategic initiatives, including new business model development, global expansion, service line growth, and the integration of acquired organizations.
Today, Chris applies his extensive experience in project governance, portfolio oversight, and operational strategy to support the successful execution of complex oncology programs. Working closely with cross-functional teams, he helps sponsors manage risk, improve predictability, and drive operational excellence across global studies, facilitating efficient innovative cancer therapy development for patients across the world.
